Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xilio Therapeutics (XLO) Treasury Shares (2024 - 2025)

Xilio Therapeutics' Treasury Shares history spans 2 years, with the latest figure at $334125.0 for Q3 2025.

  • For Q3 2025, Treasury Shares fell 25.0% year-over-year to $334125.0; the TTM value through Sep 2025 reached $334125.0, down 25.0%, while the annual FY2024 figure was $445500.0, N/A changed from the prior year.
  • Treasury Shares for Q3 2025 was $334125.0 at Xilio Therapeutics, roughly flat from $334125.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $445500.0 in Q2 2024 and bottomed at $840.0 in Q1 2024.